{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:44:37Z","timestamp":1790372677608,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Necroptosis is a form of controlled cell death implicated in neuronal loss observed in neurodegenerative diseases such as Alzheimer\u2019s disease. Down syndrome (DS) is also characterized by the presence of neuronal cell loss, but the underlying mechanisms remain unclear. Brain tissue from a mouse model of DS, Ts65dn mice, and subjects with DS were assessed for levels of necroptosis markers including receptor-interactive protein kinase 1 and 3, necroptosis executor mixed lineage kinase domain-like protein and long non-coding RNA MEG. While no differences were observed between the Ts65dn and wild type mice at a young age, levels of these markers were significantly elevated in the brains of old DS mice when compared with matched wild type controls. Assessment of post-mortem brains from DS subjects also revealed a significant increase in these necroptosis markers. Our study is the first report showing the presence of necroptosis markers in the brains of a mouse model of DS and in DS subjects. These findings support the novel idea that this form of cell death should be also considered for developing novel therapeutic strategies for DS.<\/jats:p>","DOI":"10.1038\/s41419-026-09035-y","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:24:14Z","timestamp":1782242654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Necroptosis in Down Syndrome"],"prefix":"10.1038","volume":"17","author":[{"given":"Hymavathi Reddy","family":"Vari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-613X","authenticated-orcid":false,"given":"Domenico","family":"Pratic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"9035_CR1","doi-asserted-by":"crossref","unstructured":"Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S. Down syndrome: an insight of the disease. J Biomed Sci. 2015;22:41.","DOI":"10.1186\/s12929-015-0138-y"},{"key":"9035_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1674-8301(10)60016-4","volume":"24","author":"A Ruparelia","year":"2010","unstructured":"Ruparelia A, Wiseman F, Sheppard O, Tybulewicz VL, Fisher EM. Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21. J Biomed Res. 2010;24:87\u201399.","journal-title":"J Biomed Res"},{"key":"9035_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/0028-3886.310062","volume":"69","author":"FC Gomes","year":"2021","unstructured":"Gomes FC, Mattos MF, Goloni-Bertollo EM, Pavarino EC. Alzheimer\u2019s Disease in the Down Syndrome: An Overview of Genetics and Molecular Aspects. Neurol India. 2021;69:32\u201341.","journal-title":"Neurol India"},{"key":"9035_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2021.721579","volume":"2","author":"K Sato","year":"2021","unstructured":"Sato K, Takayama KI, Hashimoto M, Inoue S. Transcriptional and Post-Transcriptional Regulations of Amyloid-beta Precursor Protein (APP) mRNA. Front Aging. 2021;2:721579.","journal-title":"Front Aging"},{"key":"9035_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94313-2","volume":"11","author":"JL Tosh","year":"2021","unstructured":"Tosh JL, Rhymes ER, Mumford P, Whittaker HT, Pulford LJ, Noy SJ, et al. Publisher Correction: Genetic dissection of down syndrome\u2011associated alterations in APP\/amyloid\u2011beta biology using mouse models. Sci Rep. 2021;11:14966.","journal-title":"Sci Rep"},{"key":"9035_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1225228","volume":"17","author":"O Hamadelseed","year":"2023","unstructured":"Hamadelseed O, Chan MKS, Wong MBF, Skutella T. Distinct neuroanatomical and neuropsychological features of Down syndrome compared to related neurodevelopmental disorders: a systematic review. Front Neurosci. 2023;17:1225228.","journal-title":"Front Neurosci"},{"key":"9035_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(87)90223-1","volume":"80","author":"DM Mann","year":"1987","unstructured":"Mann DM, Yates PO, Marcyniuk B, Ravindra CR. Loss of neurones from cortical and subcortical areas in Down\u2019s syndrome patients at middle age. Quantitative comparisons with younger Down\u2019s patients and patients with Alzheimer\u2019s disease. J Neurol Sci. 1987;80:79\u201389.","journal-title":"J Neurol Sci"},{"key":"9035_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40478-021-01300-9","volume":"10","author":"J Wegiel","year":"2022","unstructured":"Wegiel J, Flory M, Kuchna I, Nowicki K, Wegiel J, Ma SY, et al. Developmental deficits and staging of dynamics of age associated Alzheimer\u2019s disease neurodegeneration and neuronal loss in subjects with Down syndrome. Acta Neuropathol Commun. 2022;10:2.","journal-title":"Acta Neuropathol Commun"},{"key":"9035_CR9","doi-asserted-by":"crossref","unstructured":"Chi H, Chang HY, Sang TK. Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases. Int J Mol Sci. 2018;19,3082.","DOI":"10.3390\/ijms19103082"},{"key":"9035_CR10","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1038\/s41586-018-0723-9","volume":"564","author":"M Seehawer","year":"2018","unstructured":"Seehawer M, Heinzmann F, D\u2019Artista L, Harbig J, Roux PF, Hoenicke L, et al. Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer. Nature. 2018;564:E9.","journal-title":"Nature"},{"key":"9035_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41420-024-01957-w","volume":"10","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Xiang Y, Liu S, Li C, Dong J, Kong X, et al. RIPK3 signaling and its role in regulated cell death and diseases. Cell Death Discov. 2024;10:200.","journal-title":"Cell Death Discov"},{"key":"9035_CR12","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41418-021-00742-x","volume":"28","author":"AL Samson","year":"2021","unstructured":"Samson AL, Fitzgibbon C, Patel KM, Hildebrand JM, Whitehead LW, Rimes JS, et al. A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells. Cell Death Differ. 2021;28:2126\u201344.","journal-title":"Cell Death Differ"},{"key":"9035_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13195-024-01649-8","volume":"16","author":"E Carrazana","year":"2024","unstructured":"Carrazana E, Salvadores N. Therapeutic implications of necroptosis activation in Alzheimer s disease. Alzheimers Res Ther. 2024;16:275.","journal-title":"Alzheimers Res Ther"},{"key":"9035_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s40478-021-01264-w","volume":"9","author":"A Jayaraman","year":"2021","unstructured":"Jayaraman A, Htike TT, James R, Picon C, Reynolds R. TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer\u2019s disease hippocampus. Acta Neuropathol Commun. 2021;9:159.","journal-title":"Acta Neuropathol Commun"},{"key":"9035_CR15","unstructured":"Chaouhan HS, Vinod C, Mahapatra N, Yu SH, Wang IK, Chen KB, et al. Necroptosis: A Pathogenic Negotiator in Human Diseases. Int J Mol Sci. 2022;23,2714."},{"key":"9035_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JAD-151105","volume":"52","author":"A Tramutola","year":"2016","unstructured":"Tramutola A, Pupo G, Di Domenico F, Barone E, Arena A, Lanzillotta C, et al. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype. J Alzheimers Dis. 2016;52:359\u201371.","journal-title":"J Alzheimers Dis"},{"key":"9035_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neuroscience.2024.12.023","volume":"565","author":"N Baazaoui","year":"2025","unstructured":"Baazaoui N, Ben Saad MYA, Garzoli R. S. Potential role of long noncoding RNA maternally expressed gene 3 (MEG3) in the process of neurodegeneration. Neuroscience. 2025;565:487\u201398.","journal-title":"Neuroscience"},{"key":"9035_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.877711","volume":"10","author":"Z Hasina","year":"2022","unstructured":"Hasina Z, Wang N, Wang CC. Developmental Neuropathology and Neurodegeneration of Down Syndrome: Current Knowledge in Humans. Front Cell Dev Biol. 2022;10:877711.","journal-title":"Front Cell Dev Biol"},{"key":"9035_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0361-9230(86)90074-2","volume":"16","author":"JT Coyle","year":"1986","unstructured":"Coyle JT, Oster-Granite ML, Gearhart JD. The neurobiologic consequences of Down syndrome. Brain Res Bull. 1986;16:773\u201387.","journal-title":"Brain Res Bull"},{"key":"9035_CR20","first-page":"2674","volume":"16","author":"X Zuo","year":"2025","unstructured":"Zuo X. Mitochondrial Imbalance in Down Syndrome: A Driver of Accelerated Brain Aging? Aging Dis. 2025;16:2674\u201394.","journal-title":"Aging Dis"},{"key":"9035_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-025-02328-9","volume":"11","author":"G Eskander","year":"2025","unstructured":"Eskander G, Abdelhamid SG, Wahdan SA, Radwan SM. Insights on the crosstalk among different cell death mechanisms. Cell Death Discov. 2025;11:56.","journal-title":"Cell Death Discov"},{"key":"9035_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"9035_CR23","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11011-023-01203-9","volume":"38","author":"NL Anosike","year":"2023","unstructured":"Anosike NL, Adejuwon JF, Emmanuel GE, Adebayo OS, Etti-Balogun H, Nathaniel JN, et al. Necroptosis in the developing brain: role in neurodevelopmental disorders. Metab Brain Dis. 2023;38:831\u20137.","journal-title":"Metab Brain Dis"},{"key":"9035_CR24","doi-asserted-by":"crossref","unstructured":"Smith K, Colie M, Moore T, Schisler JC Die Hard: Necroptosis and its Impact on Age-Dependent Neuroinflammatory Diseases. Front Cell Death. 2024;3:1348153.","DOI":"10.3389\/fceld.2024.1348153"},{"key":"9035_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1480027","volume":"16","author":"K Yao","year":"2025","unstructured":"Yao K, Shi Z, Zhao F, Tan C, Zhang Y, Fan H, et al. RIPK1 in necroptosis and recent progress in related pharmaceutics. Front Immunol. 2025;16:1480027.","journal-title":"Front Immunol"},{"key":"9035_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20:19\u201333.","journal-title":"Nat Rev Neurosci"},{"key":"9035_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13024-023-00686-5","volume":"18","author":"L Geng","year":"2023","unstructured":"Geng L, Gao W, Saiyin H, Li Y, Zeng Y, Zhang Z, et al. MLKL deficiency alleviates neuroinflammation and motor deficits in the alpha-synuclein transgenic mouse model of Parkinson\u2019s disease. Mol Neurodegener. 2023;18:94.","journal-title":"Mol Neurodegener"},{"key":"9035_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41418-022-01061-5","volume":"30","author":"G Liccardi","year":"2023","unstructured":"Liccardi G, Annibaldi A. MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations. Cell Death Differ. 2023;30:269\u201378.","journal-title":"Cell Death Differ"},{"key":"9035_CR29","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11357-021-00448-5","volume":"43","author":"N Thadathil","year":"2021","unstructured":"Thadathil N, Nicklas EH, Mohammed S, Lewis TL Jr, Richardson A, Deepa SS. Necroptosis increases with age in the brain and contributes to age-related neuroinflammation. Geroscience. 2021;43:2345\u201361.","journal-title":"Geroscience"},{"key":"9035_CR30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, et al. Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci. 2017;20:1236\u201346.","journal-title":"Nat Neurosci"},{"key":"9035_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106523","volume":"196","author":"C Lanzillotta","year":"2024","unstructured":"Lanzillotta C, Baniowska MR, Prestia F, Sette C, Nalesso V, Perluigi M, et al. Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model. Neurobiol Dis. 2024;196:106523.","journal-title":"Neurobiol Dis"},{"key":"9035_CR32","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s12035-015-9122-5","volume":"53","author":"W Duan","year":"2016","unstructured":"Duan W, Zhang YP, Hou Z, Huang C, Zhu H, Zhang CQ, et al. Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator. Mol Neurobiol. 2016;53:1637\u201347.","journal-title":"Mol Neurobiol"},{"key":"9035_CR33","first-page":"195","volume":"41","author":"J Moon","year":"2026","unstructured":"Moon J, Ahn JH, Won MH. NeuN expression in health and disease: A histological perspective on neuronal heterogeneity. Histol Histopathol. 2026;41:195\u2013202.","journal-title":"Histol Histopathol"},{"key":"9035_CR34","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1126\/science.abp9556","volume":"381","author":"S Balusu","year":"2023","unstructured":"Balusu S, Horre K, Thrupp N, Craessaerts K, Snellinx A, Serneels L, et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease. Science. 2023;381:1176\u201382.","journal-title":"Science"},{"key":"9035_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.296","volume":"7","author":"E Lauretti","year":"2017","unstructured":"Lauretti E, Li JG, Di Meco A, Pratico D. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model. Transl Psychiatry. 2017;7:e1020.","journal-title":"Transl Psychiatry"},{"key":"9035_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep15709","volume":"5","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhang Y, Hu W, Xie S, Gong CX, Iqbal K, et al. Rapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylation. Sci Rep. 2015;5:15709.","journal-title":"Sci Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09035-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09035-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:04:29Z","timestamp":1782457469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09035-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9035"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09035-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were performed under NIH guidelines and with full institutional approval from the IACUC at Temple University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"598"}}